• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Foxp3+ CD25+ 调节性 T 细胞浸润强烈与高级别皮肤鳞状细胞癌相关,并且与 CD8+/Foxp3+ CD25+ 比值相平衡。

Intense Foxp3+ CD25+ regulatory T-cell infiltration is associated with high-grade cutaneous squamous cell carcinoma and counterbalanced by CD8+/Foxp3+ CD25+ ratio.

机构信息

Department of Health Sciences, Medical School, University of Piemonte Orientale 'A. Avogadro', 28100, Novara, Italy.

出版信息

Br J Dermatol. 2015 Jan;172(1):64-73. doi: 10.1111/bjd.13172. Epub 2014 Nov 30.

DOI:10.1111/bjd.13172
PMID:24910265
Abstract

BACKGROUND

Recent reports have revealed the therapeutic potential of cell-mediated immunity in neoplasms such as cutaneous squamous cell carcinoma (SCC).

OBJECTIVES

To define the antigenic coexpression of regulatory T cells (Tregs) and plasmacytoid dendritic cells (pDCs) and assess the CD8(+) /Foxp3(+) CD25(+) cell ratio at peritumoral and intratumoral levels in order to investigate a correlation with the aggressiveness of SCC tumours.

METHODS

We evaluated the content and distribution of Foxp3(+) CD25(+) Treg and CD123(+) pDC infiltration and assessed CD8(+) /Foxp3(+) CD25(+) cell ratio at peritumoral and intratumoral levels in 40 SCCs (20 well-differentiated, G1; and 20 moderately to poorly differentiated, G2-G3) to investigate a correlation with their aggressiveness. We determined the profiles of Tregs and CD123(+) cells; immunostained for CD4, CD8, CD123, interleukin (IL)-1 and transforming growth factor (TGF)-β1; and unequivocally double stained for Foxp3CD25.

RESULTS

Peritumorally, CD4, CD8 and Foxp3 expression showed no difference between the two groups. CD123(+) cells were fewer in G2-G3 (P = 0·0005), while Foxp3(+) CD25(+) cells were more numerous (P = 0·0005). The Foxp3(+) CD25(+) /Foxp3(+) ratio was higher in G2-G3 cases (P = 0·0005), confirming the trend in this group of activated T lymphocytes towards total Treg Foxp3(+) cells, while the CD8(+) /Foxp3(+) CD25(+) ratio was higher in G1 (P = 0·0005). Intratumorally, CD4(+) and CD8(+) cells infiltrated G2-G3 (P = 0·048) more than G1 (P = 0·004), whereas almost all cells were CD123 negative. Regarding Foxp3CD25, TGF-β1 and IL-10, they were less expressed in G1, whereas they were positive in G2-G3 (P < 0·05). The CD8(+) /Foxp3(+) CD25(+) ratio was similar to that observed in peritumoral infiltration.

CONCLUSIONS

Our data suggest that intratumoral recruitment of Tregs, high expression of TGF-β1 and IL-10, almost negative CD123+, and a low CD8(+) /Foxp3(+) CD25(+) T-cell ratio may contribute to the aggressiveness of cutaneous SCC, as already evidenced for other solid tumours.

摘要

背景

最近的报告揭示了细胞介导的免疫在皮肤鳞状细胞癌(SCC)等肿瘤中的治疗潜力。

目的

定义调节性 T 细胞(Tregs)和浆细胞样树突状细胞(pDC)的抗原共表达,并评估肿瘤周围和肿瘤内 CD8(+)/Foxp3(+)CD25(+)细胞比值,以研究其与 SCC 肿瘤侵袭性的相关性。

方法

我们评估了 Foxp3(+)CD25(+)Treg 和 CD123(+)pDC 浸润的含量和分布,并评估了 40 例 SCC(20 例分化良好,G1;20 例中至差分化,G2-G3)肿瘤周围和肿瘤内 CD8(+)/Foxp3(+)CD25(+)细胞比值,以研究其与侵袭性的相关性。我们确定了 Tregs 和 CD123(+)细胞的表型;免疫染色 CD4、CD8、CD123、白细胞介素(IL)-1 和转化生长因子(TGF)-β1;并明确地对 Foxp3CD25 进行了双重染色。

结果

肿瘤周围,两组之间 CD4、CD8 和 Foxp3 的表达没有差异。G2-G3 组的 CD123(+)细胞较少(P=0.0005),而 Foxp3(+)CD25(+)细胞较多(P=0.0005)。G2-G3 组 Foxp3(+)CD25(+)/Foxp3(+)比值较高(P=0.0005),证实了该组活化 T 淋巴细胞向总 Treg Foxp3(+)细胞的趋势,而 G1 组 CD8(+)/Foxp3(+)CD25(+)比值较高(P=0.0005)。肿瘤内,CD4(+)和 CD8(+)细胞浸润 G2-G3(P=0.048)多于 G1(P=0.004),而几乎所有细胞均为 CD123 阴性。关于 Foxp3CD25、TGF-β1 和 IL-10,它们在 G1 中表达较低,而在 G2-G3 中表达阳性(P<0.05)。CD8(+)/Foxp3(+)CD25(+)比值与肿瘤周围浸润观察到的比值相似。

结论

我们的数据表明,肿瘤内 Tregs 的募集、TGF-β1 和 IL-10 的高表达、几乎为阴性的 CD123 和低 CD8(+)/Foxp3(+)CD25(+)T 细胞比值可能有助于皮肤 SCC 的侵袭性,正如其他实体瘤所证明的那样。

相似文献

1
Intense Foxp3+ CD25+ regulatory T-cell infiltration is associated with high-grade cutaneous squamous cell carcinoma and counterbalanced by CD8+/Foxp3+ CD25+ ratio.Foxp3+ CD25+ 调节性 T 细胞浸润强烈与高级别皮肤鳞状细胞癌相关,并且与 CD8+/Foxp3+ CD25+ 比值相平衡。
Br J Dermatol. 2015 Jan;172(1):64-73. doi: 10.1111/bjd.13172. Epub 2014 Nov 30.
2
A unique subset of CD4+CD25highFoxp3+ T cells secreting interleukin-10 and transforming growth factor-beta1 mediates suppression in the tumor microenvironment.分泌白细胞介素-10和转化生长因子-β1的CD4+CD25高表达Foxp3+ T细胞的一个独特亚群介导肿瘤微环境中的抑制作用。
Clin Cancer Res. 2007 Aug 1;13(15 Pt 1):4345-54. doi: 10.1158/1078-0432.CCR-07-0472.
3
Potential role of plasmacytoid dendritic cells for FOXP3+ regulatory T cell development in human colorectal cancer and tumor draining lymph node.浆细胞样树突状细胞在人类结直肠癌和肿瘤引流淋巴结中 FOXP3+调节性 T 细胞发育中的潜在作用。
Pathol Res Pract. 2013 Dec;209(12):774-8. doi: 10.1016/j.prp.2013.08.011. Epub 2013 Sep 6.
4
Decreased suppression of CD8 and CD4 T cells by peripheral regulatory T cells in generalized vitiligo due to reduced NFATC1 and FOXP3 proteins.由于 NFATC1 和 FOXP3 蛋白减少,泛发性白癜风患者外周调节性 T 细胞对 CD8 和 CD4 T 细胞的抑制作用降低。
Exp Dermatol. 2020 Aug;29(8):759-775. doi: 10.1111/exd.14157. Epub 2020 Aug 11.
5
Tumour infiltrating CD25+ FoxP3+ regulatory T cells (Tregs) relate to tumour grade and stromal inflammation in oral squamous cell carcinoma.肿瘤浸润 CD25+FoxP3+调节性 T 细胞(Tregs)与口腔鳞状细胞癌的肿瘤分级和基质炎症有关。
J Oral Pathol Med. 2011 Sep;40(8):636-42. doi: 10.1111/j.1600-0714.2011.01020.x. Epub 2011 Feb 24.
6
B7-H4 overexpression impairs the immune response of T cells in human cervical carcinomas.B7-H4过表达会损害人宫颈癌中T细胞的免疫反应。
Hum Immunol. 2014 Dec;75(12):1203-9. doi: 10.1016/j.humimm.2014.10.002. Epub 2014 Oct 13.
7
High CCR6/CCR7 expression and Foxp3+ Treg cell number are positively related to the progression of laryngeal squamous cell carcinoma.高表达 CCR6/CCR7 和 Foxp3+Treg 细胞数量与喉鳞状细胞癌的进展呈正相关。
Oncol Rep. 2013 Sep;30(3):1380-90. doi: 10.3892/or.2013.2603. Epub 2013 Jul 8.
8
Absence of modulation of CD4+CD25 regulatory T cells in CTCL patients treated with bexarotene.贝沙罗汀治疗 CTCL 患者时 CD4+CD25 调节性 T 细胞无调节作用。
Exp Dermatol. 2010 Aug;19(8):e95-102. doi: 10.1111/j.1600-0625.2009.00993.x.
9
Comparative analyses of regulatory T cell subsets in patients with hepatocellular carcinoma: a crucial role of CD25(-) FOXP3(-) T cells.比较分析肝癌患者调节性 T 细胞亚群:CD25(-)FOXP3(-)T 细胞的关键作用。
Int J Cancer. 2012 Dec 1;131(11):2573-83. doi: 10.1002/ijc.27535. Epub 2012 Mar 29.
10
Allergy-related changes in levels of CD8+CD25+FoxP3(bright) Treg cells and FoxP3 mRNA expression in peripheral blood: the role of IL-10 or TGF-beta.外周血中CD8+CD25+FoxP3(明亮型)调节性T细胞水平及FoxP3 mRNA表达与过敏相关的变化:白细胞介素-10或转化生长因子-β的作用
J Biol Regul Homeost Agents. 2014 Jul-Sep;28(3):461-70.

引用本文的文献

1
Current and Emerging Insights into the Causes, Immunopathogenesis, and Treatment of Cutaneous Squamous Cell Carcinoma.皮肤鳞状细胞癌病因、免疫发病机制及治疗的最新与新见解
Cancers (Basel). 2025 May 19;17(10):1702. doi: 10.3390/cancers17101702.
2
Tumor-Infiltrating T Cells in Skin Basal Cell Carcinomas and Squamous Cell Carcinomas: Global Th1 Preponderance with Th17 Enrichment-A Cross-Sectional Study.皮肤基底细胞癌和鳞状细胞癌中的浸润 T 细胞:Th1 优势的全球格局与 Th17 富集——一项横断面研究。
Cells. 2024 Jun 3;13(11):964. doi: 10.3390/cells13110964.
3
Cutaneous Squamous Cell Carcinoma: An Updated Review.
皮肤鳞状细胞癌:最新综述
Cancers (Basel). 2024 May 8;16(10):1800. doi: 10.3390/cancers16101800.
4
Immunity against Non-Melanoma Skin Cancer and the Effect of Immunosuppressive Medication on Non-Melanoma Skin Cancer Risk in Solid Organ Transplant Recipients.实体器官移植受者的非黑素瘤皮肤癌免疫与免疫抑制药物对非黑素瘤皮肤癌风险的影响。
Cells. 2023 Oct 11;12(20):2441. doi: 10.3390/cells12202441.
5
Advances in cutaneous squamous cell carcinoma.皮肤鳞状细胞癌的研究进展。
Nat Rev Cancer. 2023 Jul;23(7):430-449. doi: 10.1038/s41568-023-00583-5. Epub 2023 Jun 7.
6
Identifying Candidates for Immunotherapy among Patients with Non-Melanoma Skin Cancer: A Review of the Potential Predictors of Response.非黑色素瘤皮肤癌患者中免疫治疗候选者的识别:反应潜在预测因素综述
J Clin Med. 2022 Jun 11;11(12):3364. doi: 10.3390/jcm11123364.
7
Adverse Effects of Vemurafenib on Skin Integrity: Hyperkeratosis and Skin Cancer Initiation Due to Altered MEK/ERK-Signaling and MMP Activity.维莫非尼对皮肤完整性的不良影响:由于MEK/ERK信号传导和基质金属蛋白酶活性改变导致的角化过度和皮肤癌起始。
Front Oncol. 2022 Jan 31;12:827985. doi: 10.3389/fonc.2022.827985. eCollection 2022.
8
PD-1 and beyond to Activate T Cells in Cutaneous Squamous Cell Cancers: The Case for 4-1BB and VISTA Antibodies in Combination Therapy.PD-1及其他用于激活皮肤鳞状细胞癌中T细胞的方法:4-1BB和VISTA抗体联合治疗的情况
Cancers (Basel). 2021 Jul 1;13(13):3310. doi: 10.3390/cancers13133310.
9
Assessment of Histological Features in Squamous Cell Carcinoma Involving Head and Neck Skin and Mucosa.头颈部皮肤及黏膜鳞状细胞癌组织学特征评估
J Clin Med. 2021 May 27;10(11):2343. doi: 10.3390/jcm10112343.
10
The Tumor Microenvironment in SCC: Mechanisms and Therapeutic Opportunities.皮肤鳞状细胞癌中的肿瘤微环境:机制与治疗机遇
Front Cell Dev Biol. 2021 Feb 9;9:636544. doi: 10.3389/fcell.2021.636544. eCollection 2021.